Substances · Arylcyclohexylamines
3-HO-PCP
- Preferred name
- 3-HO-PCP
- IUPAC name
- 3-(1-piperidin-1-ylcyclohexyl)phenol
- Parent CAS number (reference)
- 79787-43-2
- Molecular formula
- C17H25NO
- Molecular weight
- 259.4 g/mol
- InChIKey
- AMSXTZUCNOKUEN-UHFFFAOYSA-N
- PubChem
- CID 133277
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
3-Hydroxyphencyclidine 3HOPCP 3-HO PCP
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
3-HO-PCP
Receptor Telemetry & Mechanism of Action
High-affinity NMDA blocker (Ki = 30 nM) uniquely displaying measurable mu-opioid receptor affinity in rodent assays alongside calm, non-manic sedation.
Biotransformation & Active Metabolites
Phase II glucuronidation of the 3-phenolic hydroxyl.
Temporal Pharmacokinetics
Ultra-Potent NMDA Antagonist with mu-Opioid Affinity — Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants.
- Onset 30–75 min
- Peak Window 1.5–3 h
- Total Window 4–6 h
- Residual / Half-Life 4–10 h residual
Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
1–2 mg
Subtle threshold receptor activity (Ultra-Potent NMDA Antagonist with mu-Opioid Affinity).
Minimal baseline autonomic shift.
2–4 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
4–7 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
7–10 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
12+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.
Elevated Hazard — Avoid
Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.
Caution / Receptor Attenuation
Dramatically intensifies dissociation, confusion, and sensory immersion.
Structural Isomer & Sibling Comparison
Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants.
Physicochemical Stability & Storage
Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.
Chemically stable when kept dry, sealed, and protected from light at room temperature.
Cross-Tolerance & Dependence Profile
Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.
Chemical Architecture & Structural Profile
3-HO-PCP (3-(1-piperidin-1-ylcyclohexyl)phenol) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C17H25NO and a molar mass of 259.4 g/mol. The parent molecule is indexed under CAS registry number 79787-43-2 and in the NCBI PubChem database as CID 133277 (Standard InChIKey: AMSXTZUCNOKUEN-UHFFFAOYSA-N). This molecule shares its empirical formula (C17H25NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (79787-43-2), and spectroscopic profile.
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 3-HO-PCP is indexed within the Arylcyclohexylamines structural group. Toxicological notes (PsychonautWiki): toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for adverse side effects such as psychosis. Documented cross-tolerance class: dissociative. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- legislation.gov.uk — Misuse of Drugs Act 1971 & Psychoactive Substances Act 2016 — The National Archives (UK) (2026-11-12)